Ayca Aslan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ayca Aslan has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Emek Moroydor Derun
Department of Chemical Engineering, Yildiz Technical University, Istanbul, Turkey
3 shared publications - Emre Karaduman
Department of Bioengineering, Yildiz Technical University
3 shared publications - Mehmet Burcin Piskin
Department of Bioengineering, Yildiz Technical University, Istanbul, Turkey
3 shared publications - Selcen Ari Yuka
Faculty of Chemical and Metallurgical Engineering, Bioengineering Department, Yildiz Technical University, Istanbul, Turkey
3 shared publications - Betül Mutlu Özçınar
Department of Bioengineering, Faculty of Chemical and Metallurgical Engineering, Yıldız Technical University, İstanbul, Turkey
2 shared publications - Deniz Uygunoz
Department of Chemical Engineering, Yildiz Technical University
2 shared publications
Latest Publications
- 10 October 2026
- Published by Taylor & Francis in Drug Development and Industrial Pharmacy
- Vol. 52 (11) , 2329-2344
In vitro release kinetics and mathematical modeling of ribes nigrum extract-loaded PLGA/chitosan nanoparticles
The development of controlled drug delivery systems has become a significant focus in pharmaceutical sciences due to their potential to improve therapeutic outcomes, minimize side effects, and enha...
- 10 October 2026
- Published by Taylor & Francis in Drug Development and Industrial Pharmacy
- Vol. 52 (11) , 2329-2344
In vitro release kinetics and mathematical modeling of ribes nigrum extract-loaded PLGA/chitosan nanoparticles
The development of controlled drug delivery systems has become a significant focus in pharmaceutical sciences due to their potential to improve therapeutic outcomes, minimize side effects, and enha...
- Open Access
- 29 June 2026
- Published by Wiley in Journal of Applied Polymer Science
- Vol. 143 (36)
Development and Characterization of Ribes nigrum Extract‐Loaded PLGA /Chitosan Nanoparticles as a Vaginal Drug Delivery System for Vulvovaginal Candidiasis
Vulvovaginal candidiasis is a common fungal infection primarily caused by Candida albicans . The increasing resistance to currently used antifungal drugs underscores the urgent need for new and effective therapeutic approaches. Accordingly, nanotechnology‐based drug delivery systems have gained significant attention in recent years. In particular, polymeric nanoparticles enhance therapeutic efficacy and minimize systemic side effects by enabling prolonged and controlled drug release. Accordingly, in the present study, poly (lactic‐co‐glycolic acid) (PLGA), chitosan (CS), and CS‐coated PLGA nanoparticle systems loaded with black currant ( Ribes nigrum ) extract were developed and comparatively characterized for the treatment of vulvovaginal candidiasis. Additionally, a content analysis of extracts obtained from R. nigrum fruits harvested from different regions of Mount Uludağ (Türkiye) and processed using various drying methods was conducted. Both the extract and the loaded nanoparticles were found to be non‐cytotoxic and exhibited strong antifungal activity in vitro. The chitosan‐coated PLGA nanoparticles emerged as particularly promising candidates for vaginal application owing to their high surface charge, optimal particle size, mucoadhesive properties, and controlled release profile extending up to 2 weeks. These findings suggest that the synthesized nanocarrier system, in combination with natural bioactive compounds, may offer an innovative, biocompatible, and effective treatment option for resistant infections.
- 29 June 2026
- Published by Wiley in Journal of Applied Polymer Science
- Vol. 143 (36)
Open AccessDevelopment and Characterization of Ribes nigrum Extract‐Loaded PLGA /Chitosan Nanoparticles as a Vaginal Drug Delivery System for Vulvovaginal Candidiasis
Vulvovaginal candidiasis is a common fungal infection primarily caused by Candida albicans . The increasing resistance to currently used antifungal drugs underscores the urgent need for new and effective therapeutic approaches. Accordingly, nanotechnology‐based drug delivery systems have gained significant attention in recent years. In particular, polymeric nanoparticles enhance therapeutic efficacy and minimize systemic side effects by enabling prolonged and controlled drug release. Accordingly, in the present study, poly (lactic‐co‐glycolic acid) (PLGA), chitosan (CS), and CS‐coated PLGA nanoparticle systems loaded with black currant ( Ribes nigrum ) extract were developed and comparatively characterized for the treatment of vulvovaginal candidiasis. Additionally, a content analysis of extracts obtained from R. nigrum fruits harvested from different regions of Mount Uludağ (Türkiye) and processed using various drying methods was conducted. Both the extract and the loaded nanoparticles were found to be non‐cytotoxic and exhibited strong antifungal activity in vitro. The chitosan‐coated PLGA nanoparticles emerged as particularly promising candidates for vaginal application owing to their high surface charge, optimal particle size, mucoadhesive properties, and controlled release profile extending up to 2 weeks. These findings suggest that the synthesized nanocarrier system, in combination with natural bioactive compounds, may offer an innovative, biocompatible, and effective treatment option for resistant infections.
- Open Access
- 1 August 2025
- Published by IOP Publishing in Materials Research Express
- Vol. 12 (8) , 085602
Eco-friendly and biocompatible synthesis of reduced graphene oxide via antioxidant-assisted reduction using Momordica charantia
Reduced graphene oxide (rGO) is a versatile nanomaterial with applications in energy storage, electronic devices, biomedical fields, and environmental technologies owing to its enhanced electrical conductivity, lightweight structure, large surface area, and mechanical strength. However, the chemical reduction of graphene oxide (GO) commonly involves toxic agents such as hydrazine, raising environmental and health concerns. As a safer alternative, renewable resources, including plant extracts, have gained attention as eco-friendly and biocompatible reducing agents, particularly for biological applications. In this study, we evaluated the antioxidant capacities of various Momordica charantia (bitter melon) extracts and, for the first time, used water (MCW) and ethanol (MCE) extracts derived from fresh fruit pulp for the green synthesis and characterization of rGO. These were compared with chemically reduced counterparts, namely ascorbic acid (AA_rGO) and hydrazine (H_rGO). UV–vis spectroscopy confirmed rGO formation via decreases in the optical band gap, while Raman spectroscopy indicated a significant reduction in the intensity of the D+G band for MCW_rGO and MCE_rGO, with MCW_rGO exhibiting an ID/IG ratio similar to hydrazine-reduced rGO. SEM analysis showed densely wrinkled surface morphologies in both MCW_rGO and MCE_rGO, consistent with the typical rGO structure. Cytotoxicity assays in L929 cells indicated that both plant-based rGOs, particularly MCW_rGO, exhibited lower toxicity than GO and AA_rGO at lower concentrations. These findings demonstrate that Momordica charantia extracts serve as highly effective, eco-friendly, and economical bioreducing agent, offering a sustainable approach for the development of biocompatible materials.
- 1 August 2025
- Published by IOP Publishing in Materials Research Express
- Vol. 12 (8) , 085602
Open AccessEco-friendly and biocompatible synthesis of reduced graphene oxide via antioxidant-assisted reduction using Momordica charantia
Reduced graphene oxide (rGO) is a versatile nanomaterial with applications in energy storage, electronic devices, biomedical fields, and environmental technologies owing to its enhanced electrical conductivity, lightweight structure, large surface area, and mechanical strength. However, the chemical reduction of graphene oxide (GO) commonly involves toxic agents such as hydrazine, raising environmental and health concerns. As a safer alternative, renewable resources, including plant extracts, have gained attention as eco-friendly and biocompatible reducing agents, particularly for biological applications. In this study, we evaluated the antioxidant capacities of various Momordica charantia (bitter melon) extracts and, for the first time, used water (MCW) and ethanol (MCE) extracts derived from fresh fruit pulp for the green synthesis and characterization of rGO. These were compared with chemically reduced counterparts, namely ascorbic acid (AA_rGO) and hydrazine (H_rGO). UV–vis spectroscopy confirmed rGO formation via decreases in the optical band gap, while Raman spectroscopy indicated a significant reduction in the intensity of the D+G band for MCW_rGO and MCE_rGO, with MCW_rGO exhibiting an ID/IG ratio similar to hydrazine-reduced rGO. SEM analysis showed densely wrinkled surface morphologies in both MCW_rGO and MCE_rGO, consistent with the typical rGO structure. Cytotoxicity assays in L929 cells indicated that both plant-based rGOs, particularly MCW_rGO, exhibited lower toxicity than GO and AA_rGO at lower concentrations. These findings demonstrate that Momordica charantia extracts serve as highly effective, eco-friendly, and economical bioreducing agent, offering a sustainable approach for the development of biocompatible materials.
- 17 July 2025
- Published by Springer Nature in Mining, Metallurgy & Exploration
- Vol. 42 (4) , 2399-2413
Sericite Insights: Current Perspectives on Properties and Applications
- 17 July 2025
- Published by Springer Nature in Mining, Metallurgy & Exploration
- Vol. 42 (4) , 2399-2413
Sericite Insights: Current Perspectives on Properties and Applications
- Open Access
- 31 May 2024
- Published by Springer Nature in Amino Acids
- Vol. 56 (1) , 1-18
Therapeutic peptides for coronary artery diseases: in silico methods and current perspectives
Many drug formulations containing small active molecules are used for the treatment of coronary artery disease, which affects a significant part of the world’s population. However, the inadequate profile of these molecules in terms of therapeutic efficacy has led to the therapeutic use of protein and peptide-based biomolecules with superior properties, such as target-specific affinity and low immunogenicity, in critical diseases. Protein‒protein interactions, as a consequence of advances in molecular techniques with strategies involving the combined use of in silico methods, have enabled the design of therapeutic peptides to reach an advanced dimension. In particular, with the advantages provided by protein/peptide structural modeling, molecular docking for the study of their interactions, molecular dynamics simulations for their interactions under physiological conditions and machine learning techniques that can work in combination with all these, significant progress has been made in approaches to developing therapeutic peptides that can modulate the development and progression of coronary artery diseases. In this scope, this review discusses in silico methods for the development of peptide therapeutics for the treatment of coronary artery disease and strategies for identifying the molecular mechanisms that can be modulated by these designs and provides a comprehensive perspective for future studies.
- 31 May 2024
- Published by Springer Nature in Amino Acids
- Vol. 56 (1) , 1-18
Open AccessTherapeutic peptides for coronary artery diseases: in silico methods and current perspectives
Many drug formulations containing small active molecules are used for the treatment of coronary artery disease, which affects a significant part of the world’s population. However, the inadequate profile of these molecules in terms of therapeutic efficacy has led to the therapeutic use of protein and peptide-based biomolecules with superior properties, such as target-specific affinity and low immunogenicity, in critical diseases. Protein‒protein interactions, as a consequence of advances in molecular techniques with strategies involving the combined use of in silico methods, have enabled the design of therapeutic peptides to reach an advanced dimension. In particular, with the advantages provided by protein/peptide structural modeling, molecular docking for the study of their interactions, molecular dynamics simulations for their interactions under physiological conditions and machine learning techniques that can work in combination with all these, significant progress has been made in approaches to developing therapeutic peptides that can modulate the development and progression of coronary artery diseases. In this scope, this review discusses in silico methods for the development of peptide therapeutics for the treatment of coronary artery disease and strategies for identifying the molecular mechanisms that can be modulated by these designs and provides a comprehensive perspective for future studies.
- 4 November 2023
- Published by Springer Nature in Current Treatment Options in Cardiovascular Medicine
- Vol. 25 (11) , 689-714
Current Approaches in Cardiac Repair: Somatic and Stem Cell Exosomes
- 4 November 2023
- Published by Springer Nature in Current Treatment Options in Cardiovascular Medicine
- Vol. 25 (11) , 689-714
Current Approaches in Cardiac Repair: Somatic and Stem Cell Exosomes
- 14 June 2023
- Published by Bentham Science Publishers Ltd.
- p. 26-74
Synthetic Biology and Tissue Engineering
- 14 June 2023
- Published by Bentham Science Publishers Ltd.
- p. 26-74
Synthetic Biology and Tissue Engineering
- 1 September 2021
- Published by Elsevier in Ceramics International
- Vol. 47 (18) , 26421-26429
Development and characterization of negative air ion emitting mica- and sericite-based antimicrobial pearlescent pigments
- 1 September 2021
- Published by Elsevier in Ceramics International
- Vol. 47 (18) , 26421-26429
Development and characterization of negative air ion emitting mica- and sericite-based antimicrobial pearlescent pigments
- 1 January 2018
- Published by Bentham Science Publishers Ltd. in Current Stem Cell Research & Therapy
- Vol. 13 (6) , 447-457
Problems in Stem Cell Therapy for Cardiac Repair and Tissue Engineering Approaches Based on Graphene and Its Derivatives
Background: Today, coronary artery disease is still one of the most important causes of mortality despite advanced surgical methods, pharmacotherapies and organ transplantation. These treatment modalities are intended to prevent further progression of myocardial infarction and do not involve the repair of the damaged part. Therefore, stem cell therapy has emerged as a new approach for the treatment of coronary artery disease. However, there are some restrictions that limit the use of these cells for desired repair. The leading limitation is that newly formed cardiomyocytes do not provide electrical integrity with local cells. Objective: In this paper, we review the difficulties that limit the use of stem cell therapy in cardiac repair and emphasize the importance of the integration of stem cell with tissue scaffolds with conductivity. Furthermore, significance of using graphene scaffolds in cardiac tissue engineering is highlighted due to its conductivity features. Result: Recently, the fabrication of tissue scaffoldings has made it possible to create a biomimetic cellular environment while providing a new approach to solving these problems in treatment. Especially, the integration of stem cell therapy with graphene-based tissue scaffolds with electrical conductivity, is one of the promising new strategies to turn the success of two approaches of tissue engineering into synergistic effect in cardiac repair. Conclusion: Literature analysis has demonstrated that there are some limitations in use of stem cell therapy for successful treatment of cardiac repair and graphene-based tissue engineering approaches which are promising to solve these problems in the near future.
- 1 January 2018
- Published by Bentham Science Publishers Ltd. in Current Stem Cell Research & Therapy
- Vol. 13 (6) , 447-457
Problems in Stem Cell Therapy for Cardiac Repair and Tissue Engineering Approaches Based on Graphene and Its Derivatives
Background: Today, coronary artery disease is still one of the most important causes of mortality despite advanced surgical methods, pharmacotherapies and organ transplantation. These treatment modalities are intended to prevent further progression of myocardial infarction and do not involve the repair of the damaged part. Therefore, stem cell therapy has emerged as a new approach for the treatment of coronary artery disease. However, there are some restrictions that limit the use of these cells for desired repair. The leading limitation is that newly formed cardiomyocytes do not provide electrical integrity with local cells. Objective: In this paper, we review the difficulties that limit the use of stem cell therapy in cardiac repair and emphasize the importance of the integration of stem cell with tissue scaffolds with conductivity. Furthermore, significance of using graphene scaffolds in cardiac tissue engineering is highlighted due to its conductivity features. Result: Recently, the fabrication of tissue scaffoldings has made it possible to create a biomimetic cellular environment while providing a new approach to solving these problems in treatment. Especially, the integration of stem cell therapy with graphene-based tissue scaffolds with electrical conductivity, is one of the promising new strategies to turn the success of two approaches of tissue engineering into synergistic effect in cardiac repair. Conclusion: Literature analysis has demonstrated that there are some limitations in use of stem cell therapy for successful treatment of cardiac repair and graphene-based tissue engineering approaches which are promising to solve these problems in the near future.